How has AksharChem (AKSHARCHEM) been performing? We dig into revenue, profitability, valuation, and ownership trends.
AksharChem Revenue Trend
Revenue for AksharChem came in at ₹347 Cr in FY2025, growing 14.6% year-over-year.
Stepping back, the 10-year revenue CAGR of 5.6% shows AksharChem has been growing at a moderate, sustainable pace.
A ₹347 Cr revenue base makes AksharChem a smaller name in the Indian dyes and pigments sector.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹347 Cr | +14.6% |
| FY2024 | ₹302 Cr | -9.7% |
| FY2023 | ₹335 Cr | -12.1% |
| FY2022 | ₹381 Cr | +54.6% |
| FY2021 | ₹246 Cr | — |
View AksharChem's full 10-year revenue trend with CAGR analysis →
AksharChem Profitability
Per-share earnings moved to ₹5.94 in FY2025 from ₹-23.25 in FY2024.
Is AksharChem Undervalued
The P/E Ratio valuation pegs AksharChem's fair value at ₹172, which is 24.7% downside from the current price.
AksharChem shares are currently trading at ₹228.15.
Craytheon also calculates intrinsic value using the EPS Growth model. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹172 | 24.7% downside to fair value |
| EPS Growth | Upgrade | Upgrade |
See all valuation models for AksharChem with detailed assumptions →
AksharChem Shareholding Pattern
The promoter group has maintained its 62.7% holding through the last 4 quarters.
As of March 2026, FIIs own 0.0% of the company — down from 0.0% a year earlier.
The DII stake is flat at 0.1% as of March 2026, unchanged from the year-ago period.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 62.7% | 0.0% | 0.1% | 37.2% |
| Dec 2025 | 62.7% | 0.0% | 0.1% | 37.2% |
| Sep 2025 | 62.7% | 0.0% | 0.1% | 37.2% |
| Jun 2025 | 62.7% | 0.0% | 0.1% | 37.2% |
Track quarterly shareholding changes for AksharChem →
AksharChem Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
In FY2025, the total asset base came in at ₹4.15B, up 9.1% YoY from ₹3.81B.
Property, Plant & Equipment accounts for 66.5% of the total, ahead of Inventories (17.0%) and Receivables (9.8%).
Capital structure: 63.5% equity, 16.1% debt, 20.4% operating liabilities. Over the year, debt is up 28.8% and equity is up 1.7%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 17.94M |
| Receivables | 406.41M |
| Inventories | 704.68M |
| Property, Plant & Equipment | 2.76B |
| Investments | 38,000 |
| Intangibles & Goodwill | 1.46M |
| Other Assets | 262.80M |
| Category | Value |
|---|---|
| Equity | 2.64B |
| Short-term Debt | 534.51M |
| Long-term Debt | 133.16M |
| Trade Payables | 573.98M |
| Other Liabilities | 274.24M |
AksharChem Investment Snapshot
In summary, AksharChem (AKSHARCHEM) presents the following picture for fundamental analysts.
Revenue of ₹347 Cr in FY2025, up 14.6% year-over-year.
Long-term revenue has been compounding at 5.6% annually over 10 years.
The company is profitable, with a net margin of 1.4% and net income of ₹4.77 Cr.
The P/E Ratio model implies 24.7% downside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
Get the complete view of AksharChem on Craytheon — 10 years of financials, three valuation models, and institutional holding trends.